FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Byron

Research Profile

Chemicals & Drugs

Devices

Anatomy

Lung

Procedures

Concepts & Ideas

Phenomena

Absorption

Living Beings

Rats

Co-author Network

Publications

TOP 3
Renishkumar R Delvadia; P Worth Longest; Peter R Byron
In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans.
Peter R Byron; Michael Hindle; Carlos F Lange; P Worth Longest; Donald McRobbie; Michael J Oldham; Bo Olsson; Charles G Thiel; Herbert Wachtel; Warren H Finlay
In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
Reshma Kotian; Joanne Peart; Joan Bryner; Peter R Byron
Calibration of the modified Electrical Low-Pressure Impactor (ELPI) for use with pressurized pharmaceutical aerosols.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Byron (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Renishkumar R Delvadia; P Worth Longest; Peter R Byron
In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans.
Journal of aerosol medicine and pulmonary drug delivery 2012;25(1):32-40.
2010: Peter R Byron; Michael Hindle; Carlos F Lange; P Worth Longest; Donald McRobbie; Michael J Oldham; Bo Olsson; Charles G Thiel; Herbert Wachtel; Warren H Finlay
In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
Journal of aerosol medicine and pulmonary drug delivery 2010;23 Suppl 2():S59-69.
2009: Reshma Kotian; Joanne Peart; Joan Bryner; Peter R Byron
Calibration of the modified Electrical Low-Pressure Impactor (ELPI) for use with pressurized pharmaceutical aerosols.
Journal of aerosol medicine and pulmonary drug delivery 2009;22(1):55-65.
2009: Akihiko Kamiya; Masahiro Sakagami; Peter R Byron
Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.
Journal of pharmaceutical sciences 2009;98(3):1028-39.
2007: Yinuo Pang; Masahiro Sakagami; Peter R Byron
Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL).
Pharmaceutical research 2007;24(9):1636-44.
2007: Peter R Byron; Richard N. Dalby; Joanne Peart
Respiratory Drug Delivery Europe 2007.
Expert review of respiratory medicine 2007;1(1):39-41.
2005: Xihao Li; Frank E Blondino; Michael Hindle; William H Soine; Peter R Byron
Stability and characterization of perphenazine aerosols generated using the capillary aerosol generator.
International journal of pharmaceutics 2005;303(1-2):113-24.
2005: Shuguang Hou; Michael Hindle; Peter R Byron
Chromatographic and mass spectral characterization of budesonide and a series of structurally related corticosteroids using LC-MS.
Journal of pharmaceutical and biomedical analysis 2005;39(1-2):196-205.
2005: Yinuo Pang; Masahiro Sakagami; Peter R Byron
The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;25(4-5):369-78.
2005: Masahiro Sakagami; Peter R Byron
Respirable microspheres for inhalation: the potential of manipulating pulmonary disposition for improved therapeutic efficacy.
Clinical pharmacokinetics 2005;44(3):263-77.
2004: Akihiko Kamiya; Masahiro Sakagami; Michael Hindle; Peter R Byron
Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods.
Journal of pharmaceutical sciences 2004;93(7):1828-37.
2004: X Shen; Michael Hindle; Peter R Byron
Effect of energy on propylene glycol aerosols using the capillary aerosol generator.
International journal of pharmaceutics 2004;275(1-2):249-58.
2004: Peter R Byron
Drug delivery devices: issues in drug development.
Proceedings of the American Thoracic Society 2004;1(4):321-8.
2003: Henry J Rozycki; Peter R Byron; Greg R Elliott; Timothy Carroll; Gary R Gutcher
Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
Pediatric pulmonology 2003;35(5):375-83.
2002: Masahiro Sakagami; Peter R Byron; Frantisek Rypacek
Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lung: effects of temperature and metabolic inhibitors.
Journal of pharmaceutical sciences 2002;91(9):1958-68.
2002: David M Wilson; Joanne Peart; Billy R Martin; D Troy Bridgen; Peter R Byron; Aron H Lichtman
Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler.
Drug and alcohol dependence 2002;67(3):259-67.
2002: Martyn J Clarke; Joanne Peart; Stefano Cagnani; Peter R Byron
Adhesion of powders for inhalation: an evaluation of drug detachment from surfaces following deposition from aerosol streams.
Pharmaceutical research 2002;19(3):322-9.
2002: Masahiro Sakagami; Peter R Byron; Jürgen Venitz; Frantisek Rypacek
Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalator.
Journal of pharmaceutical sciences 2002;91(2):594-604.
2002: John N Hong; Michael Hindle; Peter R Byron
Control of particle size by coagulation of novel condensation aerosols in reservoir chambers.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 2002;15(4):359-68.
2001: S Hou; Michael Hindle; Peter R Byron
A stability-indicating HPLC assay method for budesonide.
Journal of pharmaceutical and biomedical analysis 2001;24(3):371-80.
2000: Aron H Lichtman; Joanne Peart; Justin L Poklis; D Troy Bridgen; Raj K Razdan; David M Wilson; Alphonse Poklis; Y Meng; Peter R Byron; Billy R Martin
Pharmacological evaluation of aerosolized cannabinoids in mice.
European journal of pharmacology 2000;399(2-3):141-9.
2000: C Vervaet; Peter R Byron
Polystyrene microsphere spray standards based on CFC-free inhaler technology.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 2000;13(2):105-15.
1999: C Vervaet; Peter R Byron
Drug-surfactant-propellant interactions in HFA-formulations.
International journal of pharmaceutics 1999;186(1):13-30.
1999: J Z Sun; Peter R Byron; Frantisek Rypacek
Solute absorption from the airways of the isolated rat lung. V. Charge effects on the absorption of copolymers of N(2-hydroxyethyl)-DL-aspartamide with DL-aspartic acid or dimethylaminopropyl-DL-aspartamide.
Pharmaceutical research 1999;16(7):1104-8.
1999: R A Kovelesky; Peter R Byron; Jürgen Venitz
Peptidoleukotriene (PLT) release and absorption from the airways of the isolated perfused guinea pig lung following chemical and antigenic challenge.
Pharmaceutical research 1999;16(2):321-6.
1998: F E Blondino; Peter R Byron
Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants.
Drug development and industrial pharmacy 1998;24(10):935-45.
1998: V Naini; Peter R Byron; E M Phillips
Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
Drug development and industrial pharmacy 1998;24(10):895-909.
1998: Peter R Byron
United States Pharmacopeia recommendations for the testing of inhalers.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 1998;11 Suppl 1():S11-12.
1997: Peter R Byron; Joanne Peart; John N Staniforth
Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers.
Pharmaceutical research 1997;14(6):698-705.
1997: Peter R Byron
Performance characteristics of pressurized metered dose inhalers in vitro.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 1997;10 Suppl 1():S3-6.
1996: J E Visich; Peter R Byron
High-pressure liquid chromatographic assay for the determination of thyrotropin-releasing hormone and its common metabolites in a physiological salt solution circulated through the isolated perfused rat lung.
Journal of pharmaceutical and biomedical analysis 1996;15(1):105-10.
1995: F E Blondino; Peter R Byron
The quantitative determination of aspirin and its degradation products in a model solution aerosol.
Journal of pharmaceutical and biomedical analysis 1995;13(2):111-9.
1994: Peter R Byron
Dosing reproducibility from experimental albuterol suspension metered-dose inhalers.
Pharmaceutical research 1994;11(4):580-4.
1994: Peter R Byron; Z Sun; H Katayama; F Rypacek
Solute absorption from the airways of the isolated rat lung. IV. Mechanisms of absorption of fluorophore-labeled poly-alpha,beta-[N(2-hydroxyethyl)-DL-aspartamide].
Pharmaceutical research 1994;11(2):221-5.
1994: Peter R Byron; J S Patton
Drug delivery via the respiratory tract.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 1994;7(1):49-75.
1993: R N Jashnani; Peter R Byron; Richard N. Dalby
Validation of an improved Wood's rotating disk dissolution apparatus.
Journal of pharmaceutical sciences 1993;82(6):670-1.
1993: R N Jashnani; Richard N. Dalby; Peter R Byron
Preparation, characterization, and dissolution kinetics of two novel albuterol salts.
Journal of pharmaceutical sciences 1993;82(6):613-6.
1993: E M Phillips; Peter R Byron; Richard N. Dalby
Axial ratio measurements for early detection of crystal growth in suspension-type metered dose inhalers.
Pharmaceutical research 1993;10(3):454-6.
1991: Richard N. Dalby; E M Phillips; Peter R Byron
Determination of drug solubility in aerosol propellants.
Pharmaceutical research 1991;8(9):1206-9.
1990: E M Phillips; Peter R Byron; K Fults; Anthony J Hickey
Optimized inhalation aerosols. II. Inertial testing methods for particle size analysis of pressurized inhalers.
Pharmaceutical research 1990;7(12):1228-33.
1990: R W Niven; F Rypacek; Peter R Byron
Solute absorption from the airways of the isolated rat lung. III. Absorption of several peptidase-resistant, synthetic polypeptides: poly-(2-hydroxyethyl)-aspartamides.
Pharmaceutical research 1990;7(10):990-4.
1990: R W Niven; Peter R Byron
Solute absorption from the airways of the isolated rat lung. II. Effect of surfactants on absorption of fluorescein.
Pharmaceutical research 1990;7(1):8-13.
1989: Peter R Byron; Richard N. Dalby; Anthony J Hickey
Optimized inhalation aerosols. I. The effects of spherical baffle size and position upon the output of several pressurized nonaqueous suspension formulations.
Pharmaceutical research 1989;6(3):225-9.
1988: R W Niven; Peter R Byron
Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract.
Pharmaceutical research 1988;5(9):574-9.
1988: Peter R Byron; R W Niven
A novel dosing method for drug administration to the airways of the isolated perfused rat lung.
Journal of pharmaceutical sciences 1988;77(8):693-5.
1988: Richard N. Dalby; Peter R Byron
Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions.
Pharmaceutical research 1988;5(1):36-9.
1987: Anthony J Hickey; Peter R Byron
Effect of a non-hygroscopic surfactant coating upon fluorescein absorption from the respiratory tract.
Drug design and delivery 1987;2(1):35-9.
1987: Anthony J Hickey; Peter R Byron
Effect of solution flow rate on the output of two modified commercially available jet nebulizers.
Journal of pharmaceutical sciences 1987;76(4):338-40.
1987: Peter R Byron; Richard N. Dalby
Effects of heat treatment on the permeability of polyvinyl alcohol films to a hydrophilic solute.
Journal of pharmaceutical sciences 1987;76(1):65-7.
1987: Peter R Byron; Anthony J Hickey
Spinning-disk generation and drying of monodisperse solid aerosols with output concentrations sufficient for single-breath inhalation studies.
Journal of pharmaceutical sciences 1987;76(1):60-4.
1986: Anthony J Hickey; Peter R Byron
Preparation, characterization, and controlled release from coprecipitates of fluorescein and magnesium hydroxide.
Journal of pharmaceutical sciences 1986;75(8):756-9.